Quantcast

Latest ovarian cancer Stories

2014-03-26 23:26:31

A report to the nation’s bladder cancer specialists says more of them should be taking a multidisciplinary approach to treating their patients with bladder cancer. Raleigh, NC (PRWEB) March 26, 2014 Researchers say treating the invasive form of bladder cancer with both surgery and chemotherapy can improve survival, especially if chemotherapy is delivered prior to surgery. Click here to see details of the new report, which has just been posted by Cancer Monthly. In a report presented at...

2014-03-26 16:24:58

DALLAS, March 26, 2014 /PRNewswire-iReach/ -- RnRMarketResearch.com adds "Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global" to its store that says Cancer testing has tremendous growth opportunities for the next five years. (Photo: http://photos.prnewswire.com/prnh/20140326/MN91058) Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year...

2014-03-24 23:23:11

The Foundation for Women’s Cancer and the Claudia Cohen Research Foundation announce today that Dr. Andrew Berchuck has been selected as the 2014 recipient of the Foundation for Women’s Cancer/Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Researcher. The $50,000 prize is being presented at the Society of Gynecologic Oncology 45th Annual Meeting on Women's Cancer in Tampa. Tampa, FL (PRWEB) March 24, 2014 The Foundation for Women’s Cancer and the Claudia...

2014-03-23 23:01:51

An Italian study of 22 clinical trials contains some good news and some bad news for diabetic patients treated with the drug Actos. Raleigh, NC (PRWEB) March 23, 2014 Cancer Monthly is reporting on the results of an Italian Meta-Analysis involving more than 13,197 patients who had taken either the diabetes drug Actos or another thiazolidinedione called rosiglitazone. Researchers at the Careggi Teaching Hospital in Florence, Italy scoured the medical literature for both published and...

2014-03-21 23:01:36

To protect families and save lives, western Governors have proclaimed March 22, 2014 Lynch Syndrome Hereditary Cancer Awareness Day in their states. They encourage people to learn their family history of cancers and discuss it with their physicians, for early diagosis and treatment of hereditary cancers. Laughlin, NV (PRWEB) March 21, 2014 United States Governors have proclaimed Saturday, March 22nd, Lynch Syndrome Hereditary Cancer Awareness Day in the southwestern states of Nevada,...

2014-03-21 08:24:23

ROCKVILLE, Md., March 21, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, today reported financial results for the three and 12 months ended December 31, 2013. http://photos.prnewswire.com/prnvar/20010620/ENMDLOGO The Company reported a net loss of ($1.3 million), or ($0.05) per share for the three months ended December 31, 2013. This compares with net loss of ($0.4...

2014-03-20 12:32:37

New Analysis Explores Interactions Between Clinical Risk Factors Used in Pre-surgical Assessment AUSTIN, Texas, March 20, 2014 /PRNewswire/ -- (Nasdaq: VRML) -- A new study of OVA1® clinical performance, titled "The Effect of Ovarian Imaging on the Clinical Interpretation of a Multivariate Index Assay," has been released as an online advance publication of The American Journal of Obstetrics & Gynecology.[1] The study examines the relationship between two commonly used...

2014-03-19 23:04:03

A study published in last month’s Journal of Clinical Oncology suggests that women with the BRCA1 gene mutation may significantly reduce their chances of ovarian cancer if they have their ovaries removed by age 35. Abington, PA (PRWEB) March 19, 2014 Among study participants who underwent oophorectomy (ovary removal surgery), their chances of ovarian and breast cancers decreased by 80 percent. Additionally, their risk of death from any cause by age 70 decreased 77 percent as a result of...

2014-03-19 08:30:18

PARSIPPANY, N.J., March 19, 2014 /PRNewswire-USNewswire/ -- Ferring Pharmaceuticals Inc. today announced FDA approval of new labeling for their fertility products, MENOPUR and BRAVELLE. The label update is a result of the COMBINE trial which demonstrated that both MENOPUR and BRAVELLE can be safely mixed and administered in a single injection. Approval was granted on February 19, 2014 and designates Ferring's mixed protocol as the only combination of IVF stimulation gonadotropins to...

2014-03-18 08:32:17

Experimental drug designed to fight abdominal cancers passes important test SYDNEY, March 18, 2014 /PRNewswire/ -- Novogen Limited [ASX:NRT; NASDAQ:NVGN] and its joint venture company with Yale University, CanTx Inc, today announced an important milestone with lead candidate drug, Trx-1, demonstrating a potent anti-cancer effect in mice xenografted with human ovarian cancer stem cells. http://photos.prnewswire.com/prnvar/20131220/NY36990LOGO CanTx is seeking a novel approach to...


Latest ovarian cancer Reference Libraries

Ovaries
2013-03-05 14:55:04

The ovaries are the two reproductive female organs where the eggs are produced. These are parallel to the testes in men. Formation and Orientation Each ovary is the size of an almond and is located on one side of the pelvis before the ureter and internal iliac artery but after the external iliac artery. They are attached to either side of the uterus. They are connected and release eggs to fallopian tubes, though not attached, monthly during the menstrual cycle. They also produce...

More Articles (1 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'